MORE►
Advanced Research Projects Agency for Health
Bridge Labs at Pegasus Park is at right with the campus's 18-story office tower literally bridged to it on the left. [Photo: Mauricio Rojas]
Madrid-Based Cancer Diagnostics Co. Snags Biggest Spec Suite at Pegasus Park’s Bridge Labs
by Lance Murray | Jan 23, 2025
Founded in 2012, Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal cancer, it's building a "multi-cancer platform" that can ID the unique DNA regions associated with different types of cancers.
by Quincy Preston and Lance Murray |
Sep 30, 2024
According to an economic impact report by The Perryman Group, the 26-acre Pegasus Park campus, once fully built out under its master plan, is projected to generate $1.9 billion in annual gross product and create over 15,000 jobs.
Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
Bridge Labs, the latest addition to the Pegasus Park campus, is designed to provide high-quality, flexible lab and office space for growth-stage biotech companies. "It's one-of-a-kind in the region," said Nicole Small, CEO of Lyda Hill Philanthropies.
MORE►
by Quincy Preston and Lance Murray |
Oct 20, 2023
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
MORE►
by Quincy Preston |
Oct 20, 2023
The Dallas-based customer experience hub of the Advanced Research Projects Agency for Health had its official launch yesterday at Pegasus Park. The hub's first mission: making it easier for Americans from across the country to take part in clinical trials, through the Advancing Clinical Trial Readiness Initiative.
MORE►
